Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
Alpha Cognition will present new clinical and real-world findings on its Alzheimer’s drug ZUNVEYL at the ASCP Annual Meeting (Oct. 29—Nov. 1, 2026) and the NEI Fall Congress (Nov. 5—8, 2026). Analyses indicate ZUNVEYL use in long-term care settings was associated with favorable cognitive, functional, behavioral, and sl
Alpha Cognition Inc. will present new clinical and real-world data on its Alzheimer's disease treatment ZUNVEYL® at the American Society of Consultant Pharmacists (ASCP) Annual Meeting and the Neuroscience Education Institute (NEI) Fall Congress. The presentations will cover various aspects of Alzheimer's care and ZUNV
Alpha Cognition Inc. announced that new clinical and real-world data on ZUNVEYL and acetylcholinesterase inhibitors will be presented at the ASCP Annual Meeting and NEI Fall Congress.